Cardiovascular Disease Doctors in Mokena, IL Accepting Medicare

2 Cardiovascular Disease doctors found. Showing 1 - 2

Dr. Joseph F Stella, D.O. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 10260 191st St Ste 102, Mokena, IL 60448 Phone: 708-478-4224    Fax: 708-478-4033

Dr. Dominic J Allocco, M.D. Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 19001 Old Lagrange Rd, Mokena, IL 60448 Phone: 708-478-4224    Fax: 708-478-4033

News Archive

Stevens, Penn Nursing receive RWJF grant to determine effectiveness of transitional care model

Stevens Institute of Technology and the University of Pennsylvania School of Nursing were recently funded by the Robert Wood Johnson Foundation to use policy flight simulators - pioneered by Stevens-to simulate use of the Transitional Care Model, developed by Penn Nursing.

Deoxygenated hemoglobin triggers conversion of nitrite to nitric oxide

Understanding how nitrite can improve conditions such as hypertension, heart attack and stroke has been the object of worldwide research studies. New research from Wake Forest University has potentially moved the science one step closer to this goal.

Loyola University Health System launches new program to study healthcare, costs and patient safety

Loyola University Health System has established a new Program in Health Services Research to study how doctors and nurses can provide better health care at lower costs to more people.

Lilly's ixekizumab superior to placebo, etanercept on all skin clearance measures in Phase 3 studies

Eli Lilly and Company's investigational medicine ixekizumab was statistically superior to etanercept and placebo on all skin clearance measures in Phase 3 studies, the company said today in disclosing top-line results from its pivotal UNCOVER studies in moderate-to-severe plaque psoriasis.

ADVENTRX Pharmaceuticals to raise $22.5 million

ADVENTRX Pharmaceuticals, Inc. announced today that it has entered into definitive agreements to sell 8,184,556 units in a registered direct offering to RA Capital Management, certain healthcare-focused investors, and other institutional investors for a per unit purchase price of $2.75, representing gross proceeds to ADVENTRX of approximately $22.5 million.

Read more Medical News

› Verified 3 days ago